These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36539355)

  • 21. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2021 Jan; 13(1):8-35. PubMed ID: 33185038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2015 Jan; 7(1):1-20. PubMed ID: 25545248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
    Robinson N; Sottas PE; Schumacher YO
    Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls.
    Thevis M; Thomas A; Geyer H; Schänzer W
    Growth Horm IGF Res; 2014 Dec; 24(6):276-80. PubMed ID: 25466910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing.
    Thevis M; Piper T; Thomas A
    J Pharm Biomed Anal; 2021 Oct; 205():114312. PubMed ID: 34391136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts.
    Thevis M; Schänzer W; Geyer H; Thieme D; Grosse J; Rautenberg C; Flenker U; Beuck S; Thomas A; Holland R; Dvorak J
    Br J Sports Med; 2013 Jan; 47(2):109-14. PubMed ID: 22554845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS.
    Knoop A; Planitz P; Wüst B; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1666-1672. PubMed ID: 33142033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The necessary dialogue between medicine and anti-doping for the integrity of sport and the athlete].
    Faiss R; Salamin O; Astolfi T; Saugy M
    Rev Med Suisse; 2018 Jul; 14(613):1360-1363. PubMed ID: 29998639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authorities.
    Kintz P; Gheddar L
    Clin Chim Acta; 2024 Jun; 559():119688. PubMed ID: 38670521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doping knowledge, attitudes, and practices of Ugandan athletes': a cross-sectional study.
    Muwonge H; Zavuga R; Kabenge PA
    Subst Abuse Treat Prev Policy; 2015 Sep; 10():37. PubMed ID: 26395767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive performance as a discriminator of doping status in elite athletes.
    Hopker JG; Griffin JE; Hinoveanu LC; Saugy J; Faiss R
    Drug Test Anal; 2024 May; 16(5):473-481. PubMed ID: 37602904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O; Kuipers H; van Bottenburg M
    Sports Med; 2015 Jan; 45(1):57-69. PubMed ID: 25169441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.